ABC News Amerisourcebergen Corp 101.78 $ABC LabCorp Buys

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
ABC News Amerisourcebergen Corp 101.78 $ABC

LabCorp Buys Pathology, Inc; Expands in Womens' Health
Zacks Equity Research - Zacks Investment Research - Mon Dec 14, 1:30PM CST
Laboratory Corp. of America Holdings (LH) recently agreed to purchase all the operating assets of full-service independent women's health laboratory Pathology, Inc.
ABC: 101.81 (-0.72), ALGN: 64.99 (-0.05), LH: 121.57 (+1.89), XRAY: 59.27 (-0.41)

The Largest American Companies You Haven't Heard Of
Adam Levine-Weinberg, The Motley Fool - Motley Fool - Sat Dec 12, 12:05PM CST
Most of the companies at the top of the Fortune 500 are common household names. They are massive retailers like Wal-Mart , energy giants like ExxonMobil, big automakers like Ford , and telecom titans like Verizon . The biggest companies in...
ABC: 101.81 (-0.72), ESRX: 87.03 (+1.21), MCK: 188.63 (-1.95), ADM: 34.69 (+0.51), CAH: 86.95 (+0.43), ETE: 13.24 (+0.36), DOW: 50.87 (-0.42), EPD: 22.54 (+0.38)

Look for Shares of AmerisourceBergen to Potentially Pullback after Yesterday's 1.27% Rise
Comtex SmarTrend(R) - Thu Dec 10, 4:13PM CST
AmerisourceBergen (NYSE:ABC) traded in a range yesterday that spanned from a low of $100.62 to a high of $102.42. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $101.01 on volume of 2.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABC: 101.81 (-0.72)

Watch for AmerisourceBergen to Potentially Pullback After Gaining 1.27% Yesterday
Comtex SmarTrend(R) - Thu Dec 10, 4:12PM CST
AmerisourceBergen (NYSE:ABC) traded in a range yesterday that spanned from a low of $100.62 to a high of $102.42. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $101.01 on volume of 2.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABC: 101.81 (-0.72)

Innomar Strategies Expands Patient-Centric Offerings
CNW Group - Wed Dec 09, 8:00AM CST
New technologies provide advanced adherence, patient access and enhanced health outcomes
ABC: 101.81 (-0.72)

The Cooper Companies: Strong Sell on Weak Q4, Outlook
Zacks Equity Research - Zacks Investment Research - Mon Dec 07, 11:50AM CST
On Dec 5, Zacks Investment Research downgraded The Cooper Companies Inc (COO) to a Zacks Rank #5 (Strong Sell).
ABC: 101.81 (-0.72), CAH: 86.95 (+0.43), XRAY: 59.27 (-0.41), COO: 136.32 (+1.50)

After Yesterday's Rally of 1.20% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Dec 04, 5:13PM CST
AmerisourceBergen (NYSE:ABC) traded in a range yesterday that spanned from a low of $98.54 to a high of $100.40. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $100.01 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABC: 101.81 (-0.72)

What Awaits GW Pharmaceuticals (GWPH) in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Fri Dec 04, 9:40AM CST
GW Pharmaceuticals (GWPH) is set to report fourth-quarter fiscal 2015 results on Dec 7.
ABC: 101.81 (-0.72), GWPH: 72.52 (+1.47), ABBV: 56.40 (+0.96), BMY: 70.02 (+1.38)

Align Technology Expands Overseas; Invisalign Volume Grows
Zacks Equity Research - Zacks Investment Research - Tue Dec 01, 1:30PM CST
On Nov 30, 2015, we issued an updated research report on California-based Align Technology Inc. (ALGN).
ABC: 101.81 (-0.72), ALGN: 64.99 (-0.05), CAH: 86.95 (+0.43), XRAY: 59.27 (-0.41)

LabCorp (LH) Posts Mixed Q3, Covance Synergy on Track
Zacks Equity Research - Zacks Investment Research - Tue Dec 01, 1:15PM CST
On Dec 1, 2015, we issued an updated research report on Laboratory Corporation of America Holdings (LH).
ABC: 101.81 (-0.72), ALGN: 64.99 (-0.05), CAH: 86.95 (+0.43), LH: 121.57 (+1.89)

AmerisourceBergen Introduces CareFront to Support Patients During Cancer Care
PR Newswire - Tue Dec 01, 8:00AM CST
Today, AmerisourceBergen, a global healthcare solutions leader, announced the launch of CareFront, a first-of-its-kind population health management program focused on the needs of patients diagnosed with cancer. Designed to be built into existing employer benefit packages, CareFront connects newly diagnosed cancer patients with resources for their care and explains how to avoid unnecessary medical costs. The program also offers tools to help patients understand their treatment options and financially rewards participants for enhancing the quality of their care.
ABC: 101.81 (-0.72)

Are Investors Becoming Bullish on AmerisourceBergen (ABC) Stock Now?
Zacks Equity Research - Zacks Investment Research - Mon Nov 23, 7:01AM CST
If you are looking for a stock in the Medical/Dental Supplies industry, AmerisourceBergen Corp. (ABC) could be one to watch closely
ABC: 101.81 (-0.72)

The Zacks Analyst Blog Highlights: Dow Chemical, Carnival, Boeing, Amazon and AmerisourceBergen
Zacks Equity Research - Zacks Investment Research - Thu Nov 19, 8:30AM CST
The Zacks Analyst Blog Highlights: Dow Chemical, Carnival, Boeing, Amazon and AmerisourceBergen
ABC: 101.81 (-0.72), AMZN: 667.65 (+9.74), CCL: 51.72 (+0.93), BA: 145.91 (+2.91), DOW: 50.87 (-0.42)

5 Large-Cap Stocks Delivering Big Earnings Surprises
Zacks Equity Research - Zacks Investment Research - Wed Nov 18, 12:25PM CST
Treading the path directed by market reviewers, investing in large-cap companies is a judicious decision as these are safe to bet during economic downturns and stringent credit conditions.
ABC: 101.81 (-0.72), AMZN: 667.65 (+9.74), CCL: 51.72 (+0.93), BA: 145.91 (+2.91), DOW: 50.87 (-0.42)

AmerisourceBergen Announces Changes to Its Board of Directors and Adoption of Proxy Access
Business Wire - Wed Nov 18, 5:45AM CST
AmerisourceBergen Corporation (NYSE: ABC) today announced that, following Richard C. Gozon's retirement as Chairman of the Board at the annual meeting of stockholders in March 2016, Steven H. Collis, President and Chief Executive Officer, will succeed Mr. Gozon as Chairman of the Board, and Jane E. Henney, M.D., will become the Board's Lead Independent Director. The election of Mr. Collis and Dr. Henney is contingent on their re-election as directors at the annual meeting of stockholders scheduled to be held on March 3, 2016.
ABC: 101.81 (-0.72)

SmarTrend Watching for Potential Pullback in Shares of AmerisourceBergen After 1.92% Gain
Comtex SmarTrend(R) - Tue Nov 17, 4:42PM CST
AmerisourceBergen (NYSE:ABC) traded in a range yesterday that spanned from a low of $97.33 to a high of $99.53. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $98.38 on volume of 2.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABC: 101.81 (-0.72)

AmerisourceBergen (ABC) Stock Reinstated With 'Outperform' Rating at Credit Suisse
at The Street - Tue Nov 17, 9:14AM CST
AmerisourceBergen (ABC) stock was reinstated with an 'outperform' rating at Credit Suisse on Tuesday.
ABC: 101.81 (-0.72)

3 Reasons Why AmerisourceBergen (ABC) Is a Great Growth Stock
Zacks Equity Research - Zacks Investment Research - Tue Nov 17, 7:36AM CST
AmerisourceBergen is a great growth stock as it not only has a favorable growth score, but it is ranked as a buy too
ABC: 101.81 (-0.72)


Scroll down for more posts ▼

Top 10 Most Recent News Articles

New CMO Joins ARTHEx: Boosting Innovative RNA Focus

Updated Category News Views 26

ARTHEx Biotech's Strategic Expansion Looks like ARTHEx Biotech is shaking things up with some strategic moves by bringing in Dr. Christian Freitag as their new Chief Medical Officer. Now, if you’re knee-deep in the biotech game, you'll know that having someone like Freitag onboard is akin to adding a star player to your lineup. The guy's got more than two decades of...

Continue Reading
Zinzino's October Sales Report: Eye on the Nutritional Prize

Updated Category News Views 38

Delving Into Zinzino's October Performance Alright, let’s cut to the chase and dive headfirst into what really matters—Zinzino AB’s preliminary sales report for October 2026. If you’re banking on the thriving nutritional supplement sector, this Swedish company’s numbers might just be your radar’s blip. October wasn’t just any month for these folks; it was a...

Continue Reading
Are BWIN, LFCR, PCRX Shareholder Deals Fair?

Updated Category News Views 113

What's Really Going On with BWIN, LFCR, and PCRX? Everyone talks about when there's smoke, there's fire. But in this case, it’s hard not to wonder if we're standing knee-deep in burning embers, or just a dusty old campfire. Halper Sadeh LLC is ringing the alarm bells for Baldwin Group, Lifecore Biomedical, and Pacira BioSciences, the trio tagged under NASDAQ: BWIN,...

Continue Reading
Starting Pet End-of-Life Talks: Why Timing Matters

Updated Category News Views 23

Early Conversations Can Change Everything The minute you bring it up, let's be honest, nobody likes to talk about end-of-life decisions, not even for their pets. Yet, when you think about it, biding your time until things get critical isn't doing anyone any favors, especially not the furry ones. Drs. Brandon and Paola Beebout, two piercing minds from Kearney, Nebraska,...

Continue Reading
Kendra Scott's 'Long Live Joy' Campaign Dazzles

Updated Category News Views 40

Unveiling a Holiday Spectacle: 'Long Live Joy' Party hats off, folks, because Kendra Scott is stepping up the holiday game with something they’re calling 'Long Live Joy'. Now, we're not just talking about any run-of-the-mill marketing fluff. This one’s big, it’s colorful, and it’s here to make your accessorized holidays a tad more enchanting. The Multi-Faceted...

Continue Reading
RideNow Gears Up for Earnings Amidst Industry Shifts

Updated Category News Views 185

Highway to Earnings: RideNow's Third Quarter Call Alright, folks, this is the moment the powersports crowd has been itching for. RideNow Group, Inc. (NASDAQ: RDNW) is set to roll out their third-quarter financial results on November 10, 2026. If you're in for a wild ride—pun fully intended—mark this on your calendars. With this company hogging the spotlight in the...

Continue Reading
Duolingo Faces Class Action: Investors React Strongly

Updated Category News Views 63

Duolingo's Rough Road: A Lawsuit in Motion Alright, fasten your seatbelts, because we've got a real rollercoaster here with Duolingo (NASDAQ: DUOL). You know, the language-learning app that's been pushing ads like it's going out of style? Well, investors are seeing red—not the kind you want, either. This class action lawsuit looming over them is like an unwelcome...

Continue Reading
Crocs™ Gains C2C Circularity Gold for Classic Clogs

Updated Category News Views 81

Turning Plastic into Gold Well, folks, Crocs isn't just about comfort anymore. They're wrapping their iconic Classic Clog in a shiny new accolade: Cradle to Cradle Certified® Circularity Gold Version 5.0. Imagine that—an award for making something meant to last, designed to be repurposed. They're not just slapping new paint on the same old clogs either. This...

Continue Reading
Baidu Faces Fraud Allegations: What Investors Should Know

Updated Category News Views 196

Trouble on the Horizon for Baidu Shareholders If you've got a pulse in the world of stock trading, you've likely caught wind of the storm brewing over at Baidu, Inc. (NASDAQ: BIDU). We're talking some heavy-duty allegations of securities fraud, and a class action lawsuit that's got investors scrutinizing their portfolios like never before. The lawsuit's been filed in the...

Continue Reading
AllianceBernstein Unveils Income-Focused ETF Amid Volatile Times

Updated Category News Views 40

Diving into AllianceBernstein's New Income ETF Well, today we’ve got something stirring in the financial waters over at AllianceBernstein. They’ve launched a new exchange-traded fund (ETF), aptly named the AB Equity Premium Income ETF [INK]. Now, if you’re wondering what’s cooking with this newcomer on the NASDAQ, let’s crack it open and see what’s under the...

Continue Reading

Top 5 Most Recently Viewed Articles

Keyo Elevates Rudy Dajie to CEO, Driving Innovative Payments

Updated Category News Views 237

Keyo Appoints Rudy Dajie as New CEO for Advanced Payment Solutions Keyo has recently announced a game-changing leadership appointment with Rudy Dajie stepping into the role of Chief Executive Officer. In a world where artificial intelligence is rapidly evolving, the demand for enhanced security in biometric identification is greater than ever. Innovative Biometric...

Continue Reading
Final Call for $XPL Token Access: Join the XploraDEX Journey

Updated Category News Views 162

Final Chance to Participate in $XPL Token Distribution The $XPL token distribution is entering its crucial final phase, marking an exciting moment for both investors and traders. As the presale of XploraDEX nears its closing date, many are eager to grab their share of the tokens before the opportunity slips away. This innovative platform, set on the XRP Ledger, has the...

Continue Reading
Promising Small-Cap Stocks on the Rise for Investors

Updated Category News Views 73

Small-Cap Stocks on the Verge of Growth As 2024 progresses, many analysts have identified a resurgence in small-cap stocks, suggesting that this year could mark a turning point for these often-overlooked companies. With the economic landscape shifting, especially as interest rates stabilize, there is renewed hope for sectors that faced challenges in previous years....

Continue Reading
Eli Lilly's New Oral Diabetes Treatment Python Results Exceed Expectations

Updated Category News Views 204

Eli Lilly's Groundbreaking Diabetes Treatment Trials Eli Lilly and Company (NYSE: LLY) has made significant advancements in the treatment of type 2 diabetes with their oral medication, orforglipron. Recent Phase 3 trials, ACHIEVE-2 and ACHIEVE-5, have demonstrated impressive results in controlling blood sugar levels among participants. ACHIEVE Trials Overview The...

Continue Reading
Experience Luxury and Performance with the 2025 LC 500 Convertible

Updated Category News Views 63

Introducing the 2025 LC 500 Convertible The 2025 LC 500 Convertible marks another exciting development in the luxury automobile market, maintaining its prestige and allure. This model has undergone a few updates and is ready to impress enthusiasts and casual drivers alike. Standout Features of the 2025 Model This year's model comes with notable enhancements, including...

Continue Reading